Interview: Cristina Dislich Ropke – CEO, Phytobios, Brazil
Cristina Dislich Ropke, CEO of Phytobios, a company that helps multinational and local companies turn Brazilian biodiversity into medicinal products,…
Tagged with Drug Development
Thierry Mauvernay – President and Delegate of the Board,…
Thierry Mauvernay, president and delegate of the board of Debiopharm, discusses the Swiss Group’s development over its 38 years of history, its…
Interview: Marco Cid – Director General, Investigacion…
Marco Cid, Director General of Investigacion Biomedica, shares how he successfully launched an innovative clinical research center (CRC) despite a…
Interview: Peter Tsai – Founder, CEO & Chairman, Orient…
Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into…
Interview: Peter Tsai – Founder, CEO & Chairman, Orient…
Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into…
Interview: Mark Griffiths – Group CEO, Dishman Group
“Get it done! That is what CARBOGEN AMCIS is all about!” – The CEO of the Swiss drug development and commercialization services company…
Interview: Christian Bloy – CEO & Founder, CleveXel…
Finding success in the shadows of Big Pharma and large research facilities, CleveXel serves as a bridge in the industry, specializing on selecting…
Interview: Andrew Casey, CEO, BIOTECanada
BIOTECanada is the national trade association for Canada’s biotech industry. Andrew Casey, the group’s CEO, discusses the impact of IP regulation…
